<p>Nimotuzumab Combined with Induction Chemotherapy and Concurrent Chemoradiotherapy in Unresectable Locally Advanced Hypopharyngeal Carcinoma: A Single Institution Experience in China</p>-Reference-Cited by-同舟云学术

Nimotuzumab Combined with Induction Chemotherapy and Concurrent Chemoradiotherapy in Unresectable Locally Advanced Hypopharyngeal Carcinoma: A Single Institution Experience in China

Published:2020-05 Issue: Volume:Volume 12 Page:3323-3329
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Tian Xin,Xuan Ying,Wu Rong,Gao Song

Publisher

Informa UK Limited

Subject

Oncology

Reference26 articles.

1. Efficacy and Safety of Combined Radiotherapy with EGFR Inhibitors and Chemotherapy for Laryngeal Organ Preservation in Patients with Locally Advanced Hypopharyngeal Carcinomas

2. Induction chemotherapy with TPF (Docetaxel, Carboplatin and Fluorouracil) in the treatment of locally advanced squamous cell carcinoma of the head and neck

3. Long-term oncological and functional outcomes of induction chemotherapy followed by (chemo)radiotherapy vs definitive chemoradiotherapy vs surgery-based therapy in locally advanced stage III/IV hypopharyngeal cancer: Multicenter review of 266 cases

4. Surgery vs. radiotherapy for locally advanced hypopharyngeal cancer in the contemporary era: A population-based study

5. Induction chemotherapy-based larynx preservation program for locally advanced hypopharyngeal cancer: oncologic and functional outcomes and prognostic factors

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surgical Treatment for Advanced Oropharyngeal Cancer: A Narrative Review;Medicina;2023-02-07

2. Downregulation of S100A9 Reverses Cisplatin-Resistance and Inhibits Proliferation and Migration in Hypopharyngeal Carcinoma;Journal of Oncology;2022-08-29

3. The Application of Nimotuzumab Combined With Definitive Chemoradiotherapy Toward the Treatment of Locally Advanced Cervical Esophageal Carcinoma: A Retrospective Study;Frontiers in Oncology;2022-07-06

4. Nimotuzumab Combined with Neoadjuvant or Induction Chemotherapy for Head and Neck Squamous Cell Carcinoma: A Retrospective Study;Oncologie;2022

5. Clinical Observation of Induction Chemotherapy Followed by Nimotuzumab and Radiotherapy in the Treatment of Patients with Locally Advanced Nasopharyngeal Carcinoma;Advances in Clinical Medicine;2022